DanCann Pharma A/S: Postponement of the Annual General Meeting of shareholders
COPENHAGEN, Denmark, 21 March 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that the Company has postponed its annual general meeting to the 27 April 2022.Due to internal circumstances, where key people within the Company have been affected by COVID-19, DanCann Pharma has decided to postpone its annual general meeting which should have been held on 7 May 2022, with the publication of the Annual report 2021 on 23 March 2022, to the 27 April 2022 with publication of the Annual report 2021 on 13 April 2022.